COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 554: Articles 5531-5540  | Next

Estimation of reproduction number of SARS-CoV-2 Omicron variant outbreak in Hong Kong
Allieta, M., Komlos, J., Rossi Sebastiano, D.
10.1101/2023.01.21.23284868 — Posted: 2023-01-23
Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters
Lasrado, N., Collier, A.-r., Miller, J., Hachmann, N., Liu, J., Sciacca, M., Wu, C., Anand, T., Bondzie, E., Fisher, J., Mazurek, C., Patio, R., Powers, O., Rodrigues, S., Rowe, M., Surve, N., Ty, D., Korber, B., Barouch, D. H.
10.1101/2023.01.22.525079 — Posted: 2023-01-23
Lack of Fzd6 in Ciliated Cells Suppresses Ferroptotic Pulmonary Alveolar Cell Death Induced by LPS and Coronavirus
Yuan, Q., Luan, Y., Rajendran, B. K., Compton, S., Tang, W., Wu, D.
10.1101/2023.01.23.524390 — Posted: 2023-01-23
CompCorona: A Web Portal for Comparative Analysis of the Host Transcriptome of PBMC and Lung SARS-CoV-2, SARS-CoV, and MERS-CoV
Salihoglu, R., Saracoglu, F., Sibai, M., Zengin, T., Abak Masud, B., Karasoy, O., Onal-Suzek, T.
10.1101/2023.01.21.524927 — Posted: 2023-01-23
A Novel Monoclonal Antibody Targeting a Large Surface of the Receptor Binding Motif Shows Pan-neutralizing SARS-CoV-2 Activity Including BQ.1.1 Variant
de Campos-Mata, L., Trinite, B., Modrego, A., Tejedor Vaquero, S., Pradenas, E., Rodrigo Melero, N., Carlero, D., Marfil, S., Pons-Grifols, A., Bueno-Carrasco, M. T., Santiago, C., Tarres-Freixas, F., Urrea, V., Izquierdo, N., Riveira-Munoz, E., Ballana, E., Perez, M., Vergara-Alert, J., Segales, J., Carolis, C., Arranz, R., Blanco, J., Magri, G.
10.1101/2023.01.20.524748 — Posted: 2023-01-23
Sex differences in hippocampal cytokine networks after systemic immune challenge
Finnell, J. E., Speirs, I. C., Tronson, N. C.
10.1101/378257 — Posted: 2023-01-23
Safety of bivalent omicron-containing mRNA-booster vaccines: a nationwide cohort study
Andersson, N. W., Thiesson, E. M., Hansen, J. V., Hviid, A.
10.1101/2023.01.21.23284855 — Posted: 2023-01-22
Electronic data review, client reminders, and expanded clinic hours for improving cervical cancer screening rates after COVID19 pandemic shutdowns: a multi-component quality improvement program
Ghosh, S., Fantes, J., Leschly, K., Mazul, J., Perkins, R. B.
10.1101/2023.01.20.23284607 — Posted: 2023-01-22
Assessing the effectiveness of portable HEPA air cleaners for reducing particulate matter exposure in King County, Washington homeless shelters during the COVID-19 pandemic: implications for community congregate settings
Huang, C.-H., Bui, T., Hwang, D., Shirai, J., Austin, E., Cohen, M., Gould, T., Larson, T., Novosselov, I., Tan, S., Seto, E.
10.1101/2023.01.20.23284493 — Posted: 2023-01-22
Overcrowded Housing Reduces COVID-19 Mitigation Measures and Lowers Emotional Health Among San Diego Refugees from September to November of 2020
Hassani, A., Omaleki, V., Erikat, J., Frost, E., Streuli, S., Sahid, R., Yusufi, H., Fielding-Miller, R. K.
10.1101/2023.01.20.23284851 — Posted: 2023-01-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).